Psyence Biomedical

PBM

About

Psyence Biomedical
Psyence Biomedical
PBM.US

Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd.

Profile

Company Name
Psyence Biomedical Ltd.
Market
NasdaqCM
Founded
--
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management